Inventor · disambiguated record
Søren Vestergaard Rasmussen
Also filed as: RASMUSSEN SØREN · RASMUSSEN SØREN V · RASMUSSEN SØREN VESTERGAARD
11 granted patents·4 pending applications·27 citations·filing 2016–2024
88Inventor score
Top patents by PatentIndex Score
15 records- 0195US12259380B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE·Filed 2023·Granted Mar 25, 2025·2 cites·26 claims
- 0295US11852627B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE·Filed 2022·Granted Dec 26, 2023·3 cites·11 claims
- 0394US11320421B2Oligonucleotides for inducing paternal UBE3A expressionHOFFMANN LA ROCHE·Filed 2020·Granted May 3, 2022·3 cites·16 claims
- 0494US10739332B2Oligonucleotides for inducing paternal UBE3A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Granted Aug 11, 2020·6 cites·5 claims
- 0593US10718753B2Oligonucleotides for inducing paternal UBE3A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Granted Jul 21, 2020·5 cites·9 claims
- 0690US10494633B2Oligonucleotides for inducing paternal UBE3A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Dec 3, 2019·8 cites·24 claims
- 0775US2025136984A1Oligonucleotide agonists targeting progranulinHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0870US2024182898A1ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSIONHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0968US11898145B2Enhanced oligonucleotides for inhibiting RTEL1 expressionHOFFMANN LA ROCHE·Filed 2022·Granted Feb 13, 2024·0 cites·17 claims
- 1065US12203071B2Oligonucleotide agonists targeting progranulinHOFFMANN LA ROCHE·Filed 2021·Granted Jan 21, 2025·0 cites·15 claims
- 1162US11066669B2Oligonucleotides for modulating ATXN2 expressionHOFFMANN LA ROCHE·Filed 2019·Granted Jul 20, 2021·0 cites·23 claims
- 1257US11286485B2Oligonucleotides for modulating ATXN2 expressionHOFFMANN LA ROCHE·Filed 2020·Granted Mar 29, 2022·0 cites·14 claims
- 1357US2021214727A1Enhanced oligonucleotides for inhibiting scn9a expressionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1451US2019365795A1Oligonucleotides for modulating atxn2 expressionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1549US12116576B2Oligonucleotides for modulating SCN9A expressionHOFFMANN LA ROCHE·Filed 2020·Granted Oct 15, 2024·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Søren Vestergaard Rasmussen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →